Timothy M. Block, PhDChairman and Co-Founder
Dr. Block is a Co-Founder of MERLIN Biotech and co-inventor of its hepatitis B technologies. He is founder and President of the three inter-related nonprofit organizations – the Pennsylvania Biotechnology Center, Baruch S. Blumberg Institute and Hepatitis B Foundation. With more than 30 years of experience in hepatitis B virus (HBV) and liver cancer research, Dr. Block is an internationally recognized leader in virology and drug discovery. He is co-inventor of HBV antivirals that have reached clinical trials and co-founder of several biotechnology start-up companies, including Synergy Pharmaceuticals. Dr. Block holds 18 patents, is co-author of more than 290 publications, recipient of numerous national honors, a Fellow of the American Association for the Advancement of Science, and an elected member of the U.S. National Academy of Inventors. Prior to joining the Blumberg Institute research faculty fulltime in 2015, he was a tenured Professor at Thomas Jefferson University Medical College (1984-2005) and Drexel University College of Medicine (2005-2015). He continues to serve as an Adjunct Professor at the University of Pennsylvania. Dr. Block will step down in July 2022 from his current responsibilities at the Pennsylvania Biotechnology Center, Baruch S. Blumberg Institute and Hepatitis B Foundation to devote more time to MERLIN Biotech.